CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treated With Apixaban Versus Warfarin
James B. Wetmore, Heng Yan, Charles A. Herzog, Eric D. Weinhandl, Jorge L. Reyes, Nicholas S. Roetker
Topics & Concepts
ApixabanMedicineWarfarinHazard ratioAtrial fibrillationInternal medicineKidney diseaseProportional hazards modelCohortRenal functionRetrospective cohort studyCohort studyConfidence intervalRivaroxabanAtrial Fibrillation Management and OutcomesAcute Kidney Injury ResearchPharmacovigilance and Adverse Drug Reactions